WO2010085039A2 - 노긴―유래 펩타이드 및 그의 용도 - Google Patents

노긴―유래 펩타이드 및 그의 용도 Download PDF

Info

Publication number
WO2010085039A2
WO2010085039A2 PCT/KR2009/006930 KR2009006930W WO2010085039A2 WO 2010085039 A2 WO2010085039 A2 WO 2010085039A2 KR 2009006930 W KR2009006930 W KR 2009006930W WO 2010085039 A2 WO2010085039 A2 WO 2010085039A2
Authority
WO
WIPO (PCT)
Prior art keywords
present
noggin
peptide
preventing
treating
Prior art date
Application number
PCT/KR2009/006930
Other languages
English (en)
French (fr)
Other versions
WO2010085039A3 (ko
Inventor
정용지
김영덕
김은미
송상수
홍일
조경미
김수미
한상민
Original Assignee
(주)케어젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)케어젠 filed Critical (주)케어젠
Priority to EP09838926.5A priority Critical patent/EP2383283B1/en
Priority to US13/145,390 priority patent/US8729028B2/en
Priority to ES09838926.5T priority patent/ES2548982T3/es
Priority to CN200980157908.0A priority patent/CN102348716B/zh
Priority to JP2011547757A priority patent/JP5492226B2/ja
Publication of WO2010085039A2 publication Critical patent/WO2010085039A2/ko
Publication of WO2010085039A3 publication Critical patent/WO2010085039A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 노긴-유래 펩타이드 및 이를 포함하는 발모 촉진용, 피부 상태 개선용, 항염증 또는 골질환 예방 또는 치료용 조성물에 관한 것이다. 본 발명의 노긴(Noggin)-유래 펩타이드는 천연의 인간 노긴과 동일하거나 유사한 기능을 하며 노긴과 비교하여 안정성이 보다 더 우수하며, 피부 투과도가 매우 뛰어나다. 본 발명에 따르면, 본 발명의 펩타이드를 유효성분으로 포함하는 조성물은 성장인자-관련 증후, 즉 탈모, 피부 개선 또는 창상, 성장인자 과발현 증후의 치료, 예방 또는 개선하는 데 매우 우수한 효능을 발휘한다. 따라서 상술한 본 발명의 펩타이드의 우수한 활성 및 안정성은, 의약, 의약외품 및 화장품에 매우 유리하게 적용될 수 있도록 한다.
PCT/KR2009/006930 2009-01-20 2009-11-24 노긴―유래 펩타이드 및 그의 용도 WO2010085039A2 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP09838926.5A EP2383283B1 (en) 2009-01-20 2009-11-24 Noggin-derived peptide and use thereof
US13/145,390 US8729028B2 (en) 2009-01-20 2009-11-24 Noggin-derived peptide and use thereof
ES09838926.5T ES2548982T3 (es) 2009-01-20 2009-11-24 Péptido derivado de nogina y uso del mismo
CN200980157908.0A CN102348716B (zh) 2009-01-20 2009-11-24 头蛋白-来源的肽及其用途
JP2011547757A JP5492226B2 (ja) 2009-01-20 2009-11-24 ノギン由来のペプチド及びその用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0004668 2009-01-20
KR1020090004668A KR101163171B1 (ko) 2009-01-20 2009-01-20 노긴?유래 펩타이드 및 그의 용도

Publications (2)

Publication Number Publication Date
WO2010085039A2 true WO2010085039A2 (ko) 2010-07-29
WO2010085039A3 WO2010085039A3 (ko) 2010-09-16

Family

ID=42356286

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/006930 WO2010085039A2 (ko) 2009-01-20 2009-11-24 노긴―유래 펩타이드 및 그의 용도

Country Status (7)

Country Link
US (1) US8729028B2 (ko)
EP (1) EP2383283B1 (ko)
JP (1) JP5492226B2 (ko)
KR (1) KR101163171B1 (ko)
CN (1) CN102348716B (ko)
ES (1) ES2548982T3 (ko)
WO (1) WO2010085039A2 (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101198918B1 (ko) * 2009-09-01 2012-11-07 (주)케어젠 Ｗｎｔ１０?유래 펩타이드 및 그의 용도
KR101329411B1 (ko) * 2012-05-31 2013-11-14 주식회사 엘지생활건강 피부투과성 펩타이드
KR101578901B1 (ko) 2013-09-11 2015-12-28 (주)셀아이콘랩 발모 촉진 펩타이드, 이의 제조방법, 및, 이를 함유하는 탈모방지 또는 발모촉진용 조성물
KR101600032B1 (ko) * 2013-09-26 2016-03-04 (주)피앤피바이오팜 Ｂｍｐ 활성 억제 기능을 갖는 신규 펩타이드 및 그의 용도
KR101632948B1 (ko) * 2014-05-13 2016-06-27 (주)케어젠 항염증, 골 형성 및 발모 촉진 활성을 갖는 펩타이드 및 이의 용도
KR101610861B1 (ko) * 2014-07-28 2016-04-11 (주)케어젠 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도
KR101576904B1 (ko) * 2014-07-31 2015-12-14 (주)케어젠 파골세포 분화 및 활성 억제능을 갖는 펩타이드 및 이의 용도
KR101772574B1 (ko) * 2015-07-14 2017-08-30 (주)피앤피바이오팜 모낭 세포의 재생과 성장을 촉진하는 성장인자, 고안정성 섬유아세포 성장인자 변이체 및 노긴 펩타이드를 함유한 헤어케어 화장품 조성물
KR101800877B1 (ko) * 2016-02-18 2017-11-27 (주)케어젠 발모 촉진 활성 및 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도
KR101791526B1 (ko) * 2016-02-18 2017-11-01 (주)케어젠 발모 촉진 활성을 나타내는 펩타이드 및 이의 용도
KR101831887B1 (ko) * 2016-03-09 2018-02-27 (주)케어젠 발모 촉진 활성 및 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도
WO2017159922A1 (ko) 2016-03-18 2017-09-21 (주)케어젠 피나스테라이드와 펩타이드의 결합체
KR101948238B1 (ko) * 2016-08-19 2019-02-14 (주)케어젠 미녹시딜과 펩타이드의 결합체
CN106727682A (zh) * 2017-01-20 2017-05-31 李玉红 一种用于治疗脱发的制剂
MX2019009627A (es) 2017-02-16 2019-12-11 Caregen Co Ltd Conjugado de acido salicilico y peptido.
KR101951283B1 (ko) * 2017-11-13 2019-02-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
KR102160566B1 (ko) 2019-01-16 2020-09-28 (주)케어젠 미녹시딜과 펩타이드의 결합체
KR102221365B1 (ko) * 2019-05-07 2021-03-02 (주)케어젠 트롤록스-펩타이드 결합체 및 그의 용도

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473054A (en) 1992-05-08 1995-12-05 Thomas Jefferson University IGF-1 analogs
WO1999061044A1 (en) 1998-05-28 1999-12-02 The Board Of Trustees Of The University Of Arkansas Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
WO2003048192A1 (fr) 2001-12-03 2003-06-12 Santen Pharmaceutical Co., Ltd. Nouveaux peptides et leurs utilisations en tant que medicaments
KR20060103159A (ko) 2005-03-23 2006-09-28 정용지 모발과 피부의 치료를 위한 성장인자
US20060276385A1 (en) 2003-01-13 2006-12-07 Hanjoong Jo Anti-inflammatory agents and methods of their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134656A (en) * 1992-09-03 2006-12-10 Univ California Antibodies that bind the polypeptide nogin and hybridoma capable of producing these antibodies
JP2002515730A (ja) * 1995-10-16 2002-05-28 カイロン コーポレイション 遺伝子発現を変調する因子のスクリーニング方法
US6075007A (en) * 1997-07-17 2000-06-13 Regeneron Pharmaceuticals, Inc. Modified noggin polypeptide and compositions
US20030225021A1 (en) * 2001-11-14 2003-12-04 Mckay William F. Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
WO2000013710A2 (en) * 1998-09-04 2000-03-16 Scios Inc. Hydrogel compositions for the controlled release administration of growth factors
ES2379689T3 (es) * 2003-03-14 2012-04-30 Ucb Manufacturing, Inc. A Company Incorporated Under The Laws Of The State Of Delaware Complejo de esclerostina y nogina o cordina, y agentes que modulan la formación de dicho complejo
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
WO2006105109A2 (en) * 2005-03-29 2006-10-05 The Trustees Of The University Of Pennsylvania Methods for generating new hair follicles, treating baldness, and hair removal
CN101395179B (zh) * 2006-03-06 2013-01-02 凯尔杰有限公司 具有胰岛素样生长因子-i活性的肽及其用途
KR100824396B1 (ko) * 2006-10-10 2008-04-22 (주)케어젠 상피세포 성장인자의 활성을 가지는 펩타이드 및 그의 용도
KR101198918B1 (ko) * 2009-09-01 2012-11-07 (주)케어젠 Ｗｎｔ１０?유래 펩타이드 및 그의 용도

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473054A (en) 1992-05-08 1995-12-05 Thomas Jefferson University IGF-1 analogs
WO1999061044A1 (en) 1998-05-28 1999-12-02 The Board Of Trustees Of The University Of Arkansas Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
WO2003048192A1 (fr) 2001-12-03 2003-06-12 Santen Pharmaceutical Co., Ltd. Nouveaux peptides et leurs utilisations en tant que medicaments
US20060276385A1 (en) 2003-01-13 2006-12-07 Hanjoong Jo Anti-inflammatory agents and methods of their use
KR20060103159A (ko) 2005-03-23 2006-09-28 정용지 모발과 피부의 치료를 위한 성장인자

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
"Remington's Pharmaceutical Sciences", 1995
AMERICAN JOURNAL OF PATH., vol. 165, no. 3, 2004, pages 729 - 740
COTSARELIS: "Towards a molecular understanding of hair loss and its treatment", TRENDS IN MOL. MED., vol. 7, 2001, pages 293 - 301
DOOLEY, T. P. ET AL., SKIN PHARMACOL., vol. 7, 1994, pages 188 - 200
HUSTON ET AL., METHODS IN ENZYMOLOGY, vol. 203, 1991, pages 46 - 88
KANAMI ET AL.: "Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-KB Ligand", ENDOCRINOLOGY, vol. 142, no. 8, 2001, pages 3656 - 662
KODAMA ET AL., AUTOIMMUNITY, vol. 37, 2004, pages 481 - 487
MACDONALD, N.: "Alopecia areata: identification and current treatment approaches", DERMATAL. NURS., vol. 11, 1999, pages 356 - 359
MERRIFIELD, J. AMER. CHEM. SOC., vol. 85, 1963, pages 2149 - 54
OLIVER, EMBRYOL. EXP. MORPH., vol. 15, 1966, pages 331
OLIVER, EMBRYOL. EXP. MORPH., vol. 16, 1967, pages 231
RIZZINO ET AL., CANCER RES., vol. 48, 1988, pages 4266
See also references of EP2383283A4
STENN, PAUS, PHYSIOL. REV., vol. 81, 2002, pages 449
STEWART ET AL.: "Solid Phase Peptide Synthesis", vol. 111, 1984, PIERCE CHEM. CO.
VLADIMIR A. BOTCHKAREV, AMERICAN JOURNAL OF PATHOLOGY, vol. 162, no. 3, 2003, pages 709 - 712
WHITLOW ET AL., PROTEIN ENG., vol. 6, 1993, pages 989

Also Published As

Publication number Publication date
US20110312884A1 (en) 2011-12-22
WO2010085039A3 (ko) 2010-09-16
EP2383283A4 (en) 2012-07-04
EP2383283B1 (en) 2015-07-08
JP5492226B2 (ja) 2014-05-14
EP2383283A2 (en) 2011-11-02
KR101163171B1 (ko) 2012-07-19
ES2548982T3 (es) 2015-10-22
US8729028B2 (en) 2014-05-20
JP2012515769A (ja) 2012-07-12
CN102348716B (zh) 2014-07-16
KR20100085407A (ko) 2010-07-29
CN102348716A (zh) 2012-02-08

Similar Documents

Publication Publication Date Title
WO2010085039A3 (ko) 노긴―유래 펩타이드 및 그의 용도
WO2009125925A3 (ko) 성장인자―미미킹 펩타이드 및 그의 용도
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
MX337830B (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
IL214462A0 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
WO2010001417A3 (en) Use of plant-derived recombinant growth factors in skin care
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2011009712A3 (de) Haarkonditionierende mittel mit ausgewählten kationischen siliconen und dimethicon
WO2017155232A3 (ko) 발모 촉진 활성 및/또는 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도
WO2017200659A3 (en) A method to enhance wound healing using silk-derived protein
GB201001602D0 (en) Oligopeptidic compounds and uses therof
WO2014141210A3 (en) Multifunctional immature dental pulp stem cells and therapeutic applications
WO2012014081A3 (en) Use of a composition comprising a peptidic fava bean extract for the stimulation of hair growth
MX2020010807A (es) Peptidos promotores del crecimiento y usos de los mismos.
WO2010081800A3 (en) Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
PH12019500345A1 (en) Conjugate of minoxidil and peptide
WO2008146116A3 (en) Cosmetic composition with a lifting effect for sustaining relaxed skin tissues
WO2018111042A3 (ko) 한약재 추출물을 유효성분으로 포함하는 화장료 조성물
WO2010119997A1 (ko) 형질전환 성장인자의 활성을 가지는 펩타이드 및 그의 용도
WO2005009456A3 (fr) Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l’alopecie
SG11201909144VA (en) Bacterial secretome for use in the treatment of skin lesions
EP2552940A4 (en) PEPTIDES FOR PROMOTING ANGIOGENESIS AND THEIR USE
WO2010043351A3 (de) Polyamid-5-verbindungen in kosmetischen zubereitungen
WO2012047007A3 (ko) 손톱 또는 발톱 성장 촉진용 조성물

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980157908.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09838926

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011547757

Country of ref document: JP

Ref document number: 5251/CHENP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2009838926

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13145390

Country of ref document: US